Immunotherapies L30 Flashcards
(13 cards)
immunotherapy example in rheumatoid arthritis
TNF-A inhibitors
monoclonal antibodies targeting TNF-A and cytokine receptors
T cell therapy
immunotherpay example in cancer
block using MAB to target specific cancers
MAB target specific proteins to deplete them
block/inhibit checkpoints to activate anti-tumour T cells
enhance CAR-T cell tech and personalised medicines
TNF-A
this is a cytokine involved in systemic inflammation
produced by activated macrophages
is a pyrogen and can induce fever, cell death and inflammation
overproduction can cause many disease
how the immune system controls cancer
Cancer Immunosurveillance.
Immune cells recognize abnormal antigens on cancer cells called tumor-associated antigens (TAAs) or neoantigens
Which immune cells are involved in killing cancer?
CD8+ T cells – kill tumor cells via perforin/granzymes
NK cells – target cells with low MHC I
Macrophages (M1) – pro-inflammatory, can kill tumors
Dendritic cells – present tumor antigens to T cells
What are tumor antigens?
Neoantigens – mutated self-proteins, recognized as foreign
Presented on MHC I, activate CD8+ cytotoxic T cells
What are immune checkpoints?
Proteins like CTLA-4 and PD-1 that inhibit T-cell activity. Cancer cells exploit them to avoid immune attack.
How do immune checkpoint inhibitors work?
Monoclonal antibodies block PD-1 or CTLA-4, boosting T cell activity against tumors.
What is CAR T cell therapy?
T cells are engineered to express chimeric antigen receptors (CARs) that target specific cancer antigens → enhanced killing.
How can cancer evade the immune system?
Downregulates MHC I
Secretes immunosuppressive cytokines (e.g., TGF-β)
Activates immune checkpoints (PD-L1 expression)
What are the three phases of cancer immunoediting?
Elimination – immune system destroys cancer cells
Equilibrium – surviving cancer cells persist without growing
Escape – cancer evades immune response and proliferates
What is a CAR-T cell?
: A genetically engineered T cell with a synthetic receptor (CAR) that targets tumor antigens.
: Key components of a CAR structure?
Single-chain variable fragment (scFv)
Transmembrane domain
Intracellular activation and co-stimulatory domains